GSK1349572 Hepatic Impairment Study

NCT01231529 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Hepatic Impairment
Infection, Human Immunodeficiency Virus
HIV Infections

Interventions

DRUG: GSK1349572

Sponsor

ViiV Healthcare

Collaborators

[object Object]
[object Object]